These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11040273)

  • 1. Monoclonal antibody therapy in lymphoid malignancies.
    Hainsworth JD
    Oncologist; 2000; 5(5):376-84. PubMed ID: 11040273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody therapy of lymphoma.
    Illidge TM; Bayne MC
    Expert Opin Pharmacother; 2001 Jun; 2(6):953-61. PubMed ID: 11585011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteins in haematology].
    Clarenbach RE; Mey U
    Ther Umsch; 2011 Nov; 68(11):610-7. PubMed ID: 22045523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-based therapy of non-Hodgkin's lymphoma.
    Foran JM
    Best Pract Res Clin Haematol; 2002 Sep; 15(3):449-65. PubMed ID: 12468399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ten years since the successful introduction of the first monoclonal antibody (rituximab) into the therapy of lymphomas].
    TrnenĂ½ M; Klener P
    Cas Lek Cesk; 2007; 146(7):578-85. PubMed ID: 17722844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal antibodies in hematology in 2009].
    Bonnet C; Beguin Y; De Prijck B; Witvrouw N; Hustinx R; Fillet G
    Rev Med Liege; 2009; 64(5-6):268-73. PubMed ID: 19642457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic malignancies: new developments and future treatments.
    Cheson BD
    Semin Oncol; 2002 Aug; 29(4 Suppl 13):33-45. PubMed ID: 12170431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibody treatment of malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody therapy of leukaemias and lymphomas.
    Jacobs SA; Foon KA
    Expert Opin Biol Ther; 2005 Sep; 5(9):1225-43. PubMed ID: 16120052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody therapy for lymphoma.
    Campbell P; Marcus R
    Blood Rev; 2003 Sep; 17(3):143-52. PubMed ID: 12818224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of alemtuzumab in the management of T-cell malignancies.
    Dearden C
    Semin Oncol; 2006 Apr; 33(2 Suppl 5):S44-52. PubMed ID: 16720203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody therapy for B-cell malignancies.
    Cheson BD
    Semin Oncol; 2006 Apr; 33(2 Suppl 5):S2-14. PubMed ID: 16720198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
    Fanale MA; Younes A
    Drugs; 2007; 67(3):333-50. PubMed ID: 17335294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of monoclonal antibody therapy for malignant lymphoma].
    Ogura M
    Nihon Rinsho; 2002 Mar; 60(3):505-16. PubMed ID: 11904966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab therapy of B-cell neoplasms.
    Petryk M; Grossbard ML
    Clin Lymphoma; 2000 Dec; 1(3):186-94; discussion 195-6. PubMed ID: 11707828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of CD20 monoclonal antibody therapy in B-cell malignancies.
    Czuczman MS; Gregory SA
    Leuk Lymphoma; 2010 Jun; 51(6):983-94. PubMed ID: 20367564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
    Hale G; Slavin S; Goldman JM; Mackinnon S; Giralt S; Waldmann H
    Bone Marrow Transplant; 2002 Dec; 30(12):797-804. PubMed ID: 12476271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies.
    Faderl S; Thomas DA; O'Brien S; Garcia-Manero G; Kantarjian HM; Giles FJ; Koller C; Ferrajoli A; Verstovsek S; Pro B; Andreeff M; Beran M; Cortes J; Wierda W; Tran N; Keating MJ
    Blood; 2003 May; 101(9):3413-5. PubMed ID: 12522009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.